2025 Fellows of the Society

Kannie WY Chan, Ph.D.
City University of Hong Kong
Hong Kong

For pioneering work in developing dynamic glucose enhanced MRI for imaging early changes in Alzheimer’s disease and significant contributions to the field of CEST imaging, especially many novel biomedical applications.

Hersh Chandarana, M.D.
NYU
New York, NY, USA

For making abdominopelvic MR imaging more accessible, motion robust, free-breathing, fast and easy by developing novel free-breathing and accelerated MRI methods for motion robust and motion-sorted imaging.

Catie Chang, Ph.D.
Vanderbilt University
Nashville, TN, USA

For outstanding and pioneering work in fMRI, including the development of novel approaches to study the spatio-temporal characteristics of human brain activity and their dependence on arousal state.

Maxime Descoteaux, Ph.D.
Université de Sherbrooke
Sherbrooke, QC, Canada

For seminal contributions in developing and validating state-of-the-art fiber tractography tools to better understand connectivity properties of white matter and its fiber integrity through quantitative advanced methods.

Jeffrey A. Fessler, Ph.D.
University of Michigan
Ann Arbor, MI, USA

For outstanding work in image reconstruction, including the min-max optimal method for computing fast Fourier transforms of non-uniformly sampled data, enabling widespread use of non-Cartesian sampling trajectories.

Yulin Ge, M.D.
New York University, Grossman School of Medicine
Montvale, NJ, USA

For pioneering contributions to the development of biomarkers in aging and neurodegenerative disorders using anatomic, physiological, and functional MRI techniques.

Diego Hernando, Ph.D.
University of Wisconsin
Madison, WI, USA

For outstanding contributions to quantitative MRI biomarkers of the abdomen and liver.

D.S. Fahmeed Hyder, Ph.D.
Yale University
New Haven, CT, USA

For his fundamental contributions to calibrated fMRI measurements of brain physiology and energetics, novel contrast agents for measuring ionic imbalances in disease, and understanding how total neuroenergetics supports brain function.

Shella D. Keilholz, Ph.D.
Emory University
Atlanta, GA, USA

For outstanding contributions to understanding the complex time, frequency, and spatial properties of resting-state fMRI in both animals and human brains.

Zheng-Rong Lu, Ph.D.
Case Western Reserve University
Cleveland, OH, USA

For outstanding and pioneering work in small targeted contrast agents MRI that enables clinical translatable high-resolution molecular MRI of cancer.

Vincent A. Magnotta, Ph.D.
University of Iowa
Iowa City, IA, USA

For outstanding and pioneering work in the use of magnetic resonance imaging and spectroscopy to study psychiatric disorders, including schizophrenia and bipolar disorder.

Gulin Oz, Ph.D.
University of Minnesota
Minneapolis, MN, USA

For the identification, validation and translation of MRI/MRS biomarkers for neurological diseases and her contributions to the understanding of brain metabolism in health and disease using advanced multi-nuclear MRS methods.

Ingolf Sack, Ph.D.
Charité – Universitätsmedizin Berlin
Berlin, Germany

For his outstanding contribution to the field of MR Elastography and for his constant commitment to young scientists of various disciplines in the clinical translation of research.

Allen W. Song, Ph.D.
Duke University
Durham, NC, USA

For outstanding contributions and innovations in advancing functional MRI and high resolution diffusion imaging technologies and applications.

Jacques-Donald Tournier, Ph.D.
King’s College London
London, England, UK

For important and influential contributions to diffusion MRI, particularly with respect to major advances in local modelling of fibre architecture, tractography, and group analysis of diffusion MRI data.

Matthias J.P. van Osch, Ph.D.
Gorter MRI Center
Leiden, The Netherlands

For outstanding work in arterial spin labelling and understanding the glymphatic system in healthy aging and neurodegenerative diseases.

Sudhakar K. Venkatesh, M.D., FRCR
Mayo Clinic
Rochester, MN, USA

For major contributions in exploring and clinically deploying advanced quantitative MR imaging technologies for abdominal imaging, particularly in the area of chronic liver disease, a healthcare challenge of global proportions.